Life Sciences Transformational
UK Government · United Kingdom
The TRIF Pilot provides capital grants to support large-scale R&D investments in the UK life sciences sector, focusing on innovation, health resilience, and economic growth.
Overview
The TRIF Pilot provides capital grants to support large-scale R&D investments in the UK life sciences sector, focusing on innovation, health resilience, and economic growth.
Grant details
Application Components: Expression of Interest; Application Form 1 (EOI); Application Form 2; supporting financial and project documentation
Application Platform: Online portal via Expression of Interest (EOI) process
Assessment Criteria: Health resilience and innovation impact; economic impact; financial viability; project deliverability
Decision Process: Multi-stage process including EOI screening, panel interview, and due diligence assessment
Funding Structure: Typically 10% to 20% of total project costs; projects must exceed £100 million in total value
important notes: Rolling application process; grant awards capped at £25 million; projects must be dependent on funding to proceed; compliance with UK subsidy control regulations required
Ineligible Applicants: Non-UK registered companies; organisations not meeting financial or track record requirements
Ineligible Projects: Veterinary medicines; herbal medicines; nutritional supplements; raw ingredients; standalone consumables; secondary packaging
Key Organisational Requirements: Must be a UK-registered private company; provide audited accounts or proof of secured funding; demonstrate track record in life sciences development or manufacturing
Objectives: To strengthen UK health resilience, drive innovation in life sciences, and deliver economic growth through large-scale R&D investments
Quick facts
- Status
- Open
- Closing date
- 31 Mar 2028
- Funding amount
- Up to £50m
- Funding type
- Capital Grant
- Audience
- Business
- Industry
- Health & Life Sciences